396 related articles for article (PubMed ID: 10632585)
1. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
[TBL] [Abstract][Full Text] [Related]
2. Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha.
Combs CK; Bates P; Karlo JC; Landreth GE
Neurochem Int; 2001; 39(5-6):449-57. PubMed ID: 11578780
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
Mendez M; LaPointe MC
Hypertension; 2003 Oct; 42(4):844-50. PubMed ID: 12885795
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
Mandrekar-Colucci S; Karlo JC; Landreth GE
J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.
Thieringer R; Fenyk-Melody JE; Le Grand CB; Shelton BA; Detmers PA; Somers EP; Carbin L; Moller DE; Wright SD; Berger J
J Immunol; 2000 Jan; 164(2):1046-54. PubMed ID: 10623855
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.
Landreth GE; Heneka MT
Neurobiol Aging; 2001; 22(6):937-44. PubMed ID: 11755002
[TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.
Jiang C; Ting AT; Seed B
Nature; 1998 Jan; 391(6662):82-6. PubMed ID: 9422509
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
12. Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages.
Von Knethen A A; Brüne B
FASEB J; 2001 Feb; 15(2):535-44. PubMed ID: 11156969
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells.
Oyama Y; Kurabayashi M; Akuzawa N; Nagai R
J Atheroscler Thromb; 2000; 7(2):77-82. PubMed ID: 11426586
[TBL] [Abstract][Full Text] [Related]
14. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Pelton PD; Zhou L; Demarest KT; Burris TP
Biochem Biophys Res Commun; 1999 Aug; 261(2):456-8. PubMed ID: 10425206
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.
Sastre M; Dewachter I; Landreth GE; Willson TM; Klockgether T; van Leuven F; Heneka MT
J Neurosci; 2003 Oct; 23(30):9796-804. PubMed ID: 14586007
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
Pontsler AV; St Hilaire A; Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2002 Apr; 277(15):13029-36. PubMed ID: 11809750
[TBL] [Abstract][Full Text] [Related]
19. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
20. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
Combs CK; Karlo JC; Kao SC; Landreth GE
J Neurosci; 2001 Feb; 21(4):1179-88. PubMed ID: 11160388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
